论文信息 - CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial. - 字舞流文

CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.

Manesh R. Patel | K. Mahaffey | L. Norgren | F. Rockhold | F. Fowkes | J. Berger | I. Baumgartner | J. A. Gutierrez | W. Jones | J. Blomster | P. Held | B. Katona | W. Hiatt | G. Heizer | M. Patel | W. S. Jones